Blood cancer Clinical Trials in Salt Lake City, UT

As of July 2026, 57 paid clinical trials are recruiting for Blood cancer in Salt Lake City, Utah. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

57 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

for AIDS-Related Diffuse Large B-cell Lymphoma

Sites in Salt Lake City +6 more locations

Sponsor: AIDS Malignancy Consortium

Sex: All·Age: 18+

Code: NCT05077527·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

for Acute Lymphoblastic Leukemia

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT06227026·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

for B-ALL

Sites in Salt Lake City +5 more locations

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: Up to 30

Code: NCT06579469·Recruiting·Listed Aug 2024

Apply to this trial

AlloHCT With PegINFa for Myelofibrosis

for Myelofibrosis

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT05535764·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

for Multiple Myeloma

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT05405387·Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

for Acute Myeloid Leukemia

Sites in Salt Lake City +8 more locations

Sponsor: Norman J. Lacayo

Sex: All·Age: Up to 21

Code: NCT05101551·Phase 1·Recruiting·Listed Nov 2021

Apply to this trial

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for Anal Carcinoma

Sites in Salt Lake City +7 more locations

Sponsor: AIDS Malignancy Consortium

Sex: All·Age: 18+

Code: NCT05663502·Recruiting·Listed Dec 2022

Apply to this trial

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for Hematopoietic and Lymphoid Cell Neoplasm

Sites in Salt Lake City +27 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 2 - 18

Code: NCT05711667·Phase 3·Recruiting·Listed Feb 2023

Apply to this trial

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

for Chronic Lymphocytic Leukemia

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT05183854·Phase 2·Recruiting·Listed Jan 2022

Apply to this trial

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for Grade 3b Follicular Lymphoma

Sites in Salt Lake City +98 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05890352·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

for Blastoid Variant Mantle Cell Lymphoma

Drug: Glofitamab

Sites in Salt Lake City +1 more location

Sponsor: City of Hope Medical Center

Sex: All·Age: 18 - 80

Code: NCT05861050·Phase 1, Phase 2·Recruiting·Listed May 2023

Apply to this trial

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

for Multiple Myeloma

Sites in Salt Lake City +1 more location

Sponsor: University of Illinois at Chicago

Sex: All·Age: 18+

Code: NCT05344833·Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)

for Marginal Zone Lymphoma

Drug: Rituximab

Sites in Salt Lake City +1 more location

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT06390956·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

for Chronic Lymphocytic Leukemia

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT04844528·Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

for Multiple Myeloma

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT06517017·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

Sites in Salt Lake City +28 more locations

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for Lymphoma, Non-Hodgkin

Sites in Salt Lake City +22 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07101328·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Conditions in Blood cancer (Salt Lake City, UT)

Acute myeloid leukemia (AML)· 15 Multiple myeloma· 13 Non-Hodgkin lymphoma· 12 Diffuse large B-cell lymphoma (DLBCL)· 10 Myelodysplastic syndromes (MDS)· 7 Myelofibrosis· 7 Hematologic malignancy· 7 Acute lymphoblastic leukemia· 5 Leukemia (other)· 5 Mantle cell lymphoma· 5 Chronic lymphocytic leukemia (CLL)· 4 Marginal zone lymphoma· 4 Follicular lymphoma· 3 Small lymphocytic lymphoma· 3 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Burkitt lymphoma· 1